| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/05/2003 | EP1281761A1 Hepatitis B virus pre-S1 derived synthetic polypeptides and their use thereof. |
| 02/05/2003 | EP1281760A1 Porcine circoviruses, vaccines and diagnostic reagents |
| 02/05/2003 | EP1281755A2 Variants of the human cyp2d6 gene |
| 02/05/2003 | EP1281717A2 Putative ion channel |
| 02/05/2003 | EP1281404A2 Use of antibodies against the urokinase receptor |
| 02/05/2003 | EP1281089A1 METHOD FOR CORRELATING BLOOD COAGULATION ACTIVITY WITH MARKERS IN BODY FLUIDS, e.g. URINE |
| 02/05/2003 | EP1280923A2 14094, a human trypsin family member and uses thereof |
| 02/05/2003 | EP1280919A2 Lipolytic enzyme variants |
| 02/05/2003 | EP1280918A2 Lipid metabolism enzymes |
| 02/05/2003 | EP1280917A2 21657, a human short-chain dehydrogenase and uses thereof |
| 02/05/2003 | EP1280905A2 Treatment of neoplasia / transformation using pituitary tumor transforming gene carboxy terminal peptides |
| 02/05/2003 | EP1280904A2 Pain signaling molecules |
| 02/05/2003 | EP1280903A2 Ph domain-interacting protein |
| 02/05/2003 | EP1280900A2 Dendritic cell co-stimulatory molecules |
| 02/05/2003 | EP1280899A2 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners |
| 02/05/2003 | EP1280898A1 Modified es cells and es cell-specific gene |
| 02/05/2003 | EP1280896A2 Isolated human transporter proteins, nucleic acid molecules encoding the same, and uses thereof |
| 02/05/2003 | EP1280828A2 Anthrax-specific antigen, vaccines comprising said antigen, anthrax-specific antibodies, and their uses |
| 02/05/2003 | EP1280827A1 Agonists/antagonists of the gpr56 receptor as appetite control agents |
| 02/05/2003 | EP1280823A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 02/05/2003 | EP1280817A2 Production and use of protein variants having modified immunogenecity |
| 02/05/2003 | EP1280815A1 29 human secreted proteins |
| 02/05/2003 | EP0574512B1 Redirection of cellular immunity by receptor chimeras |
| 02/05/2003 | CN1395617A A humanized antibody to surface antigen S of hepatitis B virus and preparing method thereof |
| 02/05/2003 | CN1395581A Recombinant antibodies to human IL-1 beta |
| 02/05/2003 | CN1395104A Inhibitor-1 antibody of hepatic cell growth factor activitor and its use |
| 02/05/2003 | CN1394959A Human ring finger proteinase code sequence, its preparation method and application |
| 02/05/2003 | CN1394955A Human cytokine receptor protein, its code sequence, preparation method and application |
| 02/05/2003 | CN1394873A Human calcium ion/calmodulin dependent protein kinase II inhibitory protein and its application |
| 02/05/2003 | CN1100876C DNA encoding human paplilloma virus type 18 |
| 02/04/2003 | US6515111 Monoclonal antibody which inhibits transendothelial migration of human mononuclear leukocytes |
| 02/04/2003 | US6515110 Multivalent antigen-binding proteins |
| 02/04/2003 | US6515107 Human metabotropic glutamate receptor 7 subtypes |
| 02/04/2003 | US6515105 Vascular Endothelial Growth Factor binding to extracellular domain of NP-1 (Neuropilin-1); bioactive complexes; mediate useful cell responses or antagonize undesired biological activities; angiogenesis; cell differentiation |
| 02/04/2003 | US6514761 Methods of using BCL-2 for the therapeutic treatment and prevention of diseases |
| 02/04/2003 | US6514758 Methods for treatment of HIV and other infections using A T cell or viral activator and anti-retroviral combination therapy |
| 02/04/2003 | US6514753 Expression vectors for producing modified proteins |
| 02/04/2003 | US6514745 Oncoprotein protein kinase |
| 02/04/2003 | US6514726 Aspergillus fumigatus acetyl coenzyme-A carboxylase genes and polypeptides and uses thereof |
| 02/04/2003 | US6514724 Isolated polynucleotide encoding a polypeptide which has high binding affinity. |
| 02/04/2003 | US6514713 Using immunoassay to determine amount of polypeptide in fluid sample; Used in diagnosis of breast, ovarian, colorectal and prostate cancer. |
| 02/04/2003 | US6514712 Probe for the early detection of displasias in multilayer tesselated epithelium and for the diagnosis and therapy of carcinomas |
| 02/04/2003 | US6514707 Methods for detection of prion protein as an indication of transmissible spongiform encephalophathies |
| 02/04/2003 | US6514697 Methods for detection of Crytosporidium species and isolates and for diagnosis of Cryptosporidium infections |
| 02/04/2003 | US6514688 Separating, detecting or quantifying biological materials using magnetic cross-linked polyvinyl alcohol particles |
| 02/04/2003 | US6514513 Costimulatory blockade and mixed chimerism in transplantation |
| 02/04/2003 | US6514498 Modified/chimeric superantigens and their use |
| 02/04/2003 | US6514497 Inhibition of LERK-2-mediated cell adhesion |
| 02/04/2003 | CA2109815C Antibody preparation |
| 02/04/2003 | CA2063810C Production of vascular endothelial cell growth factor |
| 02/04/2003 | CA2060325C Polypeptides with a dopaminergic receptor activity; nucleic acids coding for these polypeptides and use of the latter for screening active substances on said polypeptides |
| 02/03/2003 | WO2002016548A2 Novel g protein-coupled receptor |
| 02/03/2003 | CA2418130A1 Novel g protein-coupled receptor |
| 01/31/2003 | WO2002012338A2 Screening method |
| 01/31/2003 | CA2417972A1 Screening method |
| 01/31/2003 | CA2391621A1 Novel variants of the human cyp2d6 gene |
| 01/30/2003 | WO2003008930A2 Lfa-1 binding agents that recognize neoepitopes |
| 01/30/2003 | WO2003008584A1 HUMAN TYPE ANTIHUMAN IgE RECEPTOR ANTIBODY AND ANTIBODY FRAGMENT |
| 01/30/2003 | WO2003008581A1 p53-DEPENDENT APOPTOSIS-INDUCING PROTEIN AND METHOD OF SCREENING APOPTOSIS REGULATOR |
| 01/30/2003 | WO2003008579A2 Polynucleotides expressed in dendritic cells and polypeptides encoded thereby |
| 01/30/2003 | WO2003008574A1 Mutations in ion channels |
| 01/30/2003 | WO2003008560A2 A novel g protein-coupled receptor, gave8 |
| 01/30/2003 | WO2003008548A2 Mouse farnesoid x receptor sequences for use in comparative pharmacology |
| 01/30/2003 | WO2003008541A2 Extracellular junctional adhesion molecules |
| 01/30/2003 | WO2003008537A2 Epitope sequences |
| 01/30/2003 | WO2003008454A2 Glycoprotein vi fusion proteins |
| 01/30/2003 | WO2003008452A2 Bispecific monoclonal antibodies to il-12 and il-18 receptors |
| 01/30/2003 | WO2003008451A2 Modification of human variable domains |
| 01/30/2003 | WO2003008449A1 Ntb-a, a surface molecule involved in natural killer cells activity |
| 01/30/2003 | WO2003008448A2 Novel human proton-gated channels |
| 01/30/2003 | WO2003008444A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | WO2003008443A2 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/30/2003 | WO2003007989A1 Anti-microbial targeting chimeric pharmaceutical |
| 01/30/2003 | WO2003007988A1 Liquid formulation comprising cetuximab and a fatty acid ester of polyoxyethylene sorbitan |
| 01/30/2003 | WO2003007978A1 Alpha-fetoprotein peptides and uses thereof |
| 01/30/2003 | WO2003007971A1 Improved heteropolymer complexes and methods for their use |
| 01/30/2003 | WO2003007889A2 Therapeutic agents comprising pro-apoptotic proteins |
| 01/30/2003 | WO2003007881A2 Antibodies specific for nanotubes and related methods and compositions |
| 01/30/2003 | WO2003007874A2 Anti-tumor activity from reptile serum |
| 01/30/2003 | WO2003007803A2 Methods for diagnosing and treating alzheimer's disease and parkinson's disease |
| 01/30/2003 | WO2003007800A2 Methods for diagnosing and treating diseases and conditions of the digestive system and cancer |
| 01/30/2003 | WO2003007794A2 Invasion complex and methods of targeting |
| 01/30/2003 | WO2002090986A9 Colon cancer antigen panel |
| 01/30/2003 | WO2002068585A9 Tip39 polypeptides |
| 01/30/2003 | WO2002050257A3 Method for the production of polyfructans |
| 01/30/2003 | WO2002036166A3 Compositions for stimulating cd45 and thereby suppressing microglial activation associated with alzheimer's disease |
| 01/30/2003 | WO2002034918A3 E. coli 0157:h7 c1 esterase inhibitor-binding protein stce and uses thereof |
| 01/30/2003 | WO2002030321A3 Bird diagnostics and treatments |
| 01/30/2003 | WO2002026988A3 Human drug metabolizing enzymes |
| 01/30/2003 | WO2002020763A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/30/2003 | WO2002018583A3 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 01/30/2003 | WO2002016567A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/30/2003 | WO2002002634A3 Human extracellular matrix and cell adhesion polypeptides |
| 01/30/2003 | WO2001092877A3 Method of identifying and/or isolating stem cells |
| 01/30/2003 | WO2001091792A9 Anti-adhesion molecule antibody to treat inflammation and cancer by inducing the idiotypic network |
| 01/30/2003 | WO2001090359A3 G-protein coupled receptors |
| 01/30/2003 | WO2001079286A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 01/30/2003 | WO2001064877A9 Human schizophrenia gene |
| 01/30/2003 | US20030023993 Nucleotide sequences coding polypeptide for use in the treatment of necrosis, septic shock and inflammation |
| 01/30/2003 | US20030023070 For diagnosis, prophylaxis and therapy; therapy of cancer |